Standard Nuclear Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	3.36	3.14	-
Revenue Growth	-	-	-
Cost of Revenue	11.56	7.67	-
Gross Profit	-8.2	-4.53	-
Selling, General & Admin	7.66	4.5	1.34
Research & Development	-	-	60.6
Operating Expenses	7.66	4.5	61.94
Operating Income	-15.86	-9.03	-61.94
Interest & Investment Income	0.89	0.36	-
Other Non Operating Income (Expenses)	-	-7.73	-51.26
EBT Excluding Unusual Items	-14.97	-16.39	-113.19
Other Unusual Items	-	0.85	-
Pretax Income	-14.97	-15.54	-113.19
Net Income	-14.97	-15.54	-113.19
Net Income to Common	-14.97	-15.54	-113.19
Net Income Growth	-	-	-
Shares Outstanding (Basic)	11	28	13
Shares Outstanding (Diluted)	11	28	13
Shares Change	-	123.68%	-
EPS (Basic)	-1.43	-0.56	-9.04
EPS (Diluted)	-1.43	-0.56	-9.04
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-22.18	-15.66	-5.14
Free Cash Flow Per Share	-2.11	-0.56	-0.41
Gross Margin	-244.42%	-144.36%	-
Operating Margin	-472.68%	-287.65%	-
Profit Margin	-446.08%	-494.92%	-
Free Cash Flow Margin	-660.91%	-498.71%	-
EBITDA	-15.27	-8.68	-61.93
EBITDA Margin	-	-276.47%	-
D&A For EBITDA	0.59	0.35	0
EBIT	-15.86	-9.03	-61.94
EBIT Margin	-	-287.65%	-
Revenue as Reported	3.36	3.14	-

SEC Filings: 10-K · 10-Q